A citation-based method for searching scientific literature


List of co-cited articles
643 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
712
33

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
472
24

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
707
17

A randomized study of screening for ovarian cancer: a multicenter study in Japan.
H Kobayashi, Y Yamada, T Sado, M Sakata, S Yoshida, R Kawaguchi, S Kanayama, H Shigetomi, S Haruta, Y Tsuji,[...]. Int J Gynecol Cancer 2008
149
17

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
Fabiola Medeiros, Michael G Muto, Yonghee Lee, Julia A Elvin, Michael J Callahan, Colleen Feltmate, Judy E Garber, Daniel W Cramer, Christopher P Crum. Am J Surg Pathol 2006
555
15

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
J M Piek, P J van Diest, R P Zweemer, J W Jansen, R J Poort-Keesom, F H Menko, J J Gille, A P Jongsma, G Pals, P Kenemans,[...]. J Pathol 2001
469
14

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
564
14

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Aarti Sharma, Sara Lewis, Susan Davies, Susan Philpott, Alberto Lopes,[...]. Lancet Oncol 2009
501
13

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
17

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015
116
13

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Michael J Callahan, Christopher P Crum, Fabiola Medeiros, David W Kindelberger, Julia A Elvin, Judy E Garber, Colleen M Feltmate, Ross S Berkowitz, Michael G Muto. J Clin Oncol 2007
332
12

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
Lucy Gilbert, Olga Basso, John Sampalis, Igor Karp, Claudia Martins, Jing Feng, Sabrina Piedimonte, Louise Quintal, Agnihotram V Ramanakumar, Janet Takefman,[...]. Lancet Oncol 2012
92
13




Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening.
John Rensselaer van Nagell, Rachel Ware Miller, Christopher P DeSimone, Frederick R Ueland, Iwona Podzielinski, Scott T Goodrich, Jeff W Elder, Bin Huang, Richard J Kryscio, Edward John Pavlik. Obstet Gynecol 2011
63
17

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Usha Menon, Steven J Skates, Sara Lewis, Adam N Rosenthal, Barnaby Rufford, Karen Sibley, Nicola Macdonald, Anne Dawnay, Arjun Jeyarajah, Robert C Bast,[...]. J Clin Oncol 2005
150
9


TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
Elisabetta Kuhn, Robert J Kurman, Russell Vang, Ann Smith Sehdev, Guangming Han, Robert Soslow, Tian-Li Wang, Ie-Ming Shih. J Pathol 2012
228
9

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Isaac Kinde, Chetan Bettegowda, Yuxuan Wang, Jian Wu, Nishant Agrawal, Ie-Ming Shih, Robert Kurman, Fanny Dao, Douglas A Levine, Robert Giuntoli,[...]. Sci Transl Med 2013
184
9

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Christopher P Crum, Ronny Drapkin, Alexander Miron, Tan A Ince, Michael Muto, David W Kindelberger, Yonghee Lee. Curr Opin Obstet Gynecol 2007
324
9

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
72
12

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.
Russell Vang, Kala Visvanathan, Amy Gross, Emily Maambo, Mamta Gupta, Elisabetta Kuhn, Rose Fanghong Li, Brigitte M Ronnett, Jeffrey D Seidman, Anna Yemelyanova,[...]. Int J Gynecol Pathol 2012
80
10

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
Joseph W Carlson, Alexander Miron, Elke A Jarboe, Mana M Parast, Michelle S Hirsch, Yonghee Lee, Michael G Muto, David Kindelberger, Christopher P Crum. J Clin Oncol 2008
238
8

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013
104
8


Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
John R van Nagell, Paul D DePriest, Frederick R Ueland, Christopher P DeSimone, Amy L Cooper, J Matt McDonald, Edward J Pavlik, Richard J Kryscio. Cancer 2007
130
8

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Adam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, Philip Badman, Susan Philpott, Jessica Mozersky, Richard Hadwin, Fay H Cafferty, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2013
87
9

Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.
Amelie M Lutz, Juergen K Willmann, Frank V Cochran, Pritha Ray, Sanjiv S Gambhir. PLoS Med 2008
53
13

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.
Amy Finch, Patricia Shaw, Barry Rosen, Joan Murphy, Steven A Narod, Terence J Colgan. Gynecol Oncol 2006
258
7


A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
Ann K Folkins, Elke A Jarboe, Aasia Saleemuddin, Yonghee Lee, Michael J Callahan, Ronny Drapkin, Judy E Garber, Michael G Muto, Shelley Tworoger, Christopher P Crum. Gynecol Oncol 2008
177
7

Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
Shinichi Yachida, Siân Jones, Ivana Bozic, Tibor Antal, Rebecca Leary, Baojin Fu, Mihoko Kamiyama, Ralph H Hruban, James R Eshleman, Martin A Nowak,[...]. Nature 2010
7

Tubal ligation and the risk of ovarian cancer: review and meta-analysis.
D Cibula, M Widschwendter, O Májek, L Dusek. Hum Reprod Update 2011
158
7

The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention".
Christopher P Crum, Frank D McKeon, Wa Xian. Clin Obstet Gynecol 2012
49
14

Rethinking ovarian cancer: recommendations for improving outcomes.
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, Andy Berchuck, Jonathan S Berek, James D Brenton, George Coukos, Christopher C Crum, Ronny Drapkin, Dariush Etemadmoghadam,[...]. Nat Rev Cancer 2011
809
7

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Ruth Perets, Gregory A Wyant, Katherine W Muto, Jonathan G Bijron, Barish B Poole, Kenneth T Chin, Jin Yun H Chen, Anders W Ohman, Corey D Stepule, Soongu Kwak,[...]. Cancer Cell 2013
313
7

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Steven J Skates, Mark H Greene, Saundra S Buys, Phuong L Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez, John O Schorge, Mark Sherman, Mary B Daly,[...]. Clin Cancer Res 2017
48
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
6

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.
B B J Hermsen, R I Olivier, R H M Verheijen, M van Beurden, J A de Hullu, L F Massuger, C W Burger, C T Brekelmans, M J Mourits, G H de Bock,[...]. Br J Cancer 2007
96
6

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
865
6

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
C Bethan Powell, Eric Kenley, Lee-May Chen, Beth Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie, John Ziegler. J Clin Oncol 2005
252
6

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
Katherine Leeper, Rochelle Garcia, Elizabeth Swisher, Barbara Goff, Benjamin Greer, Pamela Paley. Gynecol Oncol 2002
189
6

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
439
6

Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Christopher G Przybycin, Robert J Kurman, Brigitte M Ronnett, Ie-Ming Shih, Russell Vang. Am J Surg Pathol 2010
298
6

Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule.
Charles W Drescher, Chirag Shah, Jason Thorpe, Kathy O'Briant, Garnet L Anderson, Christine D Berg, Nicole Urban, Martin W McIntosh. J Clin Oncol 2013
43
13

Predictive value of symptoms for early detection of ovarian cancer.
Mary Anne Rossing, Kristine G Wicklund, Kara L Cushing-Haugen, Noel S Weiss. J Natl Cancer Inst 2010
90
6

Development of an ovarian cancer symptom index: possibilities for earlier detection.
Barbara A Goff, Lynn S Mandel, Charles W Drescher, Nicole Urban, Shirley Gough, Kristi M Schurman, Joshua Patras, Barry S Mahony, M Robyn Andersen. Cancer 2007
227
6

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
194
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.